SlideShare a Scribd company logo
1 of 17
CALCIUM REGULATION
PRESENTED BY:
MOHD MONISH
M PHARM (PHARMACOLOGY) 2ND SEMESTER
SPER, JAMIA HAMDARD
PRESENTATION OUTLINE
 Calcium Homeostasis…………………………………………………………………….03-04
 Calcium regulating hormones…………………………………………………………..05
 Parathyroid Hormone……………………………………………………………………..06-09
 Vitamin D…………………………………………………………………………………….10-12
 Calcitonin…………………………………………………………………………………....13-14
 Physiological actions of calcium……………………………………………………….15
 References…………………………………………………………………………………..16
2
CALCIUM HOMEOSTASIS
 Calcium is an essential element that serves an
important role in skeletal mineralization. More than
99% of the calcium in the body is stored in bone as
hydroxyapatite, 0.99% in blood and 0.01% inside
cells.
 Normal blood calcium level ranges between 9-10.5
mg / dL.
 Calcium in the blood exists in three forms:
• Free- ionized- diffusible, biologically active.
• Bound to anions- e.g. phosphate – diffusible, not
biologically active.
• Bound to proteins- (mainly albumin) – not
diffusible, not biologically active.
3
ABSORPTION OF CALCIUM
Agents Increases absorption
 Low calcium intake
 Vitamin D
 PTH
Agents decreases absorption
 Oxalates, phosphates .
 Glucocorticoids
 Phenytoin
• Facilitated diffusion from entire small intestine
• Carrier mediated active transport under influence of vitamin D in duodenum.
4
For controlling the
plasma levels of
calcium, we have
three hormones.
Parathyroid
(PTH) - that increases
blood calcium.
Vitamin D3 - that
increases blood
calcium.
Calcitonin - that
reduces blood
calcium.
CALCIUM REGULATING HORMONES
5
 Parathyroid Hormone is a polypeptide hormone that helps to
regulate plasma Ca2+ by affecting bone resorption/formation,
renal Ca2+ excretion/reabsorption, and calcitriol synthesis.
 In kidneys, it increases calcium reabsorption mainly from
distal convoluted tubule, and proximal part of collecting duct,
and inhibits phosphate reabsorption in the proximal tubule,
increasing its excretion in urine. PTH also increases the
conversion of 25-hydroxycholecalciferol to the 1,25-
dihydroxycholecalciferol, which increases the absorption of
calcium ions from the GI tract, indirectly.
PARATHYROID HORMONE (PTH)
6
KIDNEY
• PTH binds to receptors on cells
of PCT inhibits sodium
phosphate co-transporters
decrease sodium phosphate
reabsorption thus increase
urinary phosphate excretion.
• PTH binds to receptors on
principal cells of DCT
sodium/calcium channel
upregulation increase
calcium reabsorption from
urine.
7
BONE
• PTH increases extracellular calcium levels is by stimulating
osteoclast formation in bone. 8
INTESTINE
• PTH increases
extracellular calcium
levels is by helping
convert
cholecalciferol into
Vit D. It does so by
upregulating
enzyme 1α-
hydroxylase.
9
 Vitamin D is a fat-soluble steroid. It includes Ergocalciferol, which is called as vitamin D2,
and cholecalciferol known as vitamin D3, derived from pro-vitamin D (7-dehydrocholesterol).
dehydrocholesterol).
 Activation of Vitamin D occurs in 2 steps.
• First: Cholecalciferol is converted into 25-hydroxycholecalciferol in liver.
• Second: 25-hydroxycholecalciferol is converted into 1,25-dihydroxycholecalciferol in kidney,
by enzyme 1α-hydroxylase enzyme.
 Now, this 1,25-dihydroxycholecalciferol increases the calcium level in plasma.
VITAMIN D
10
Activation of Vit-
D
11
ACTIONS OF VITAMIN D
 Increase absorption of calcium and phosphate from intestine.
 Increase reabsorption of calcium and phosphate from bone.
 Increase tubular reabsorption of calcium and phosphate in kidneys.
 Cell differentiation: particularly of collagen and skin epithelium.
 Important for cell mediated immunity and coordination of the immune response.
12
 Calcitonin is secreted by the parafollicular
cells, often called as C cells, situated amongst
the follicles in the butterfly-shaped thyroid
gland. Its normal plasma level is 1 to 2 ng/dL.
 Calcitonin is a hypocalcemic hormone whose
actions generally oppose those of PTH.
• In Kidneys - Calcitonin inhibits reabsorption of
calcium and phosphate from renal tubule and
excreting them.
• On Bones - Calcitonin inhibits osteoclasts and
stimulates osteoblastic activity. Thus,
decreasing plasma calcium as a result.
CALCITONIN
13
EFFECT ON BONE
• Calcitonin binds to calcitonin
receptor on basal osteoclast
surface – G protein coupled
receptor activation –
Adenylate cyclase activation –
ATP converted to 3’,5’-cAMP –
Increase cAMP levels –
decrease no. of osteocyte
arms formed – decrease bone
resorption.
14
Physiological
Functions of Calcium
Controls of
Excitability of
Nerves and Muscle
Maintains integrity of
cell membrane and
regulates cell adhesion
Essential for
muscular
contraction
Blood clotting
Formation of bone and
teeth
Hormonal and
neurotransmitter
release
Second messenger in
some hormonal action
15
REFERENCES
• Osmosis from Elsevier, Calcium and phosphate regulation, n.d.
https://www.osmosis.org/notes/Calcium_and_Phosphate_Hormonal_Regulation, accessed 15/04/2023.
• Thomas D. Nolin and Peter A. Friedman, Agents affecting mineral ion homeostasis and bone turnover,
The pharmacological basis of therapeutics, Goodman & Gilman’s, 13th edn. MC Graw Hill Education:
2018: 887-906.
16
THANK YOU
17

More Related Content

Similar to Calcium regulation.pptx

Topic 8-1 Са и вода анг.pptx
Topic 8-1  Са и вода анг.pptxTopic 8-1  Са и вода анг.pptx
Topic 8-1 Са и вода анг.pptx
DadaKaroli
 
Drugs affecting calcium balance
Drugs affecting calcium balanceDrugs affecting calcium balance
Drugs affecting calcium balance
anujrims
 

Similar to Calcium regulation.pptx (20)

Calcium
CalciumCalcium
Calcium
 
Calcium regulation
Calcium regulationCalcium regulation
Calcium regulation
 
Parathyroid, calcitonin
Parathyroid, calcitoninParathyroid, calcitonin
Parathyroid, calcitonin
 
Topic 8-1 Са и вода анг.pptx
Topic 8-1  Са и вода анг.pptxTopic 8-1  Са и вода анг.pptx
Topic 8-1 Са и вода анг.pptx
 
Endocrine regulation of calcium metabolism
Endocrine regulation of calcium metabolism Endocrine regulation of calcium metabolism
Endocrine regulation of calcium metabolism
 
Drugs affecting calcium balance
Drugs affecting calcium balanceDrugs affecting calcium balance
Drugs affecting calcium balance
 
Calcium homeostasis
Calcium homeostasisCalcium homeostasis
Calcium homeostasis
 
Calcium
CalciumCalcium
Calcium
 
calcitonin.pptx
calcitonin.pptxcalcitonin.pptx
calcitonin.pptx
 
Drug acting on Calcium Presentation .pptx
Drug acting on Calcium Presentation .pptxDrug acting on Calcium Presentation .pptx
Drug acting on Calcium Presentation .pptx
 
Cal. po4 by dr tasnim
Cal. po4 by dr tasnimCal. po4 by dr tasnim
Cal. po4 by dr tasnim
 
Blood calcium
Blood calcium Blood calcium
Blood calcium
 
Drugs affecting calcium balance
Drugs affecting calcium balanceDrugs affecting calcium balance
Drugs affecting calcium balance
 
Calcium Presentation
Calcium PresentationCalcium Presentation
Calcium Presentation
 
Role of PTH , Calcitonin , Calcitriol in Regulation of Plasma-Calcium Level
Role of PTH , Calcitonin , Calcitriol in Regulation of Plasma-Calcium LevelRole of PTH , Calcitonin , Calcitriol in Regulation of Plasma-Calcium Level
Role of PTH , Calcitonin , Calcitriol in Regulation of Plasma-Calcium Level
 
Calcium metabolism
Calcium metabolismCalcium metabolism
Calcium metabolism
 
PTH & Calcitonin for MBBS, BDS, Lab. Med..pptx
PTH & Calcitonin for MBBS, BDS, Lab. Med..pptxPTH & Calcitonin for MBBS, BDS, Lab. Med..pptx
PTH & Calcitonin for MBBS, BDS, Lab. Med..pptx
 
Seminar on Calcium metabolism
Seminar on Calcium metabolismSeminar on Calcium metabolism
Seminar on Calcium metabolism
 
Calcium metabolism made asy
Calcium  metabolism made asyCalcium  metabolism made asy
Calcium metabolism made asy
 
Calcium
CalciumCalcium
Calcium
 

More from ashharnomani

Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
ashharnomani
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
ashharnomani
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptx
ashharnomani
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
ashharnomani
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptx
ashharnomani
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptx
ashharnomani
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptx
ashharnomani
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
ashharnomani
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
ashharnomani
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
ashharnomani
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
ashharnomani
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
ashharnomani
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
ashharnomani
 

More from ashharnomani (20)

Protein microarray .pptx
Protein microarray .pptxProtein microarray .pptx
Protein microarray .pptx
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptx
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptx
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptx
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptx
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptx
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
 
GH RECEPTORS.pptx
GH RECEPTORS.pptxGH RECEPTORS.pptx
GH RECEPTORS.pptx
 
antihelminthic.ppt
antihelminthic.pptantihelminthic.ppt
antihelminthic.ppt
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
 

Recently uploaded

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 

Recently uploaded (20)

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 

Calcium regulation.pptx

  • 1. CALCIUM REGULATION PRESENTED BY: MOHD MONISH M PHARM (PHARMACOLOGY) 2ND SEMESTER SPER, JAMIA HAMDARD
  • 2. PRESENTATION OUTLINE  Calcium Homeostasis…………………………………………………………………….03-04  Calcium regulating hormones…………………………………………………………..05  Parathyroid Hormone……………………………………………………………………..06-09  Vitamin D…………………………………………………………………………………….10-12  Calcitonin…………………………………………………………………………………....13-14  Physiological actions of calcium……………………………………………………….15  References…………………………………………………………………………………..16 2
  • 3. CALCIUM HOMEOSTASIS  Calcium is an essential element that serves an important role in skeletal mineralization. More than 99% of the calcium in the body is stored in bone as hydroxyapatite, 0.99% in blood and 0.01% inside cells.  Normal blood calcium level ranges between 9-10.5 mg / dL.  Calcium in the blood exists in three forms: • Free- ionized- diffusible, biologically active. • Bound to anions- e.g. phosphate – diffusible, not biologically active. • Bound to proteins- (mainly albumin) – not diffusible, not biologically active. 3
  • 4. ABSORPTION OF CALCIUM Agents Increases absorption  Low calcium intake  Vitamin D  PTH Agents decreases absorption  Oxalates, phosphates .  Glucocorticoids  Phenytoin • Facilitated diffusion from entire small intestine • Carrier mediated active transport under influence of vitamin D in duodenum. 4
  • 5. For controlling the plasma levels of calcium, we have three hormones. Parathyroid (PTH) - that increases blood calcium. Vitamin D3 - that increases blood calcium. Calcitonin - that reduces blood calcium. CALCIUM REGULATING HORMONES 5
  • 6.  Parathyroid Hormone is a polypeptide hormone that helps to regulate plasma Ca2+ by affecting bone resorption/formation, renal Ca2+ excretion/reabsorption, and calcitriol synthesis.  In kidneys, it increases calcium reabsorption mainly from distal convoluted tubule, and proximal part of collecting duct, and inhibits phosphate reabsorption in the proximal tubule, increasing its excretion in urine. PTH also increases the conversion of 25-hydroxycholecalciferol to the 1,25- dihydroxycholecalciferol, which increases the absorption of calcium ions from the GI tract, indirectly. PARATHYROID HORMONE (PTH) 6
  • 7. KIDNEY • PTH binds to receptors on cells of PCT inhibits sodium phosphate co-transporters decrease sodium phosphate reabsorption thus increase urinary phosphate excretion. • PTH binds to receptors on principal cells of DCT sodium/calcium channel upregulation increase calcium reabsorption from urine. 7
  • 8. BONE • PTH increases extracellular calcium levels is by stimulating osteoclast formation in bone. 8
  • 9. INTESTINE • PTH increases extracellular calcium levels is by helping convert cholecalciferol into Vit D. It does so by upregulating enzyme 1α- hydroxylase. 9
  • 10.  Vitamin D is a fat-soluble steroid. It includes Ergocalciferol, which is called as vitamin D2, and cholecalciferol known as vitamin D3, derived from pro-vitamin D (7-dehydrocholesterol). dehydrocholesterol).  Activation of Vitamin D occurs in 2 steps. • First: Cholecalciferol is converted into 25-hydroxycholecalciferol in liver. • Second: 25-hydroxycholecalciferol is converted into 1,25-dihydroxycholecalciferol in kidney, by enzyme 1α-hydroxylase enzyme.  Now, this 1,25-dihydroxycholecalciferol increases the calcium level in plasma. VITAMIN D 10
  • 12. ACTIONS OF VITAMIN D  Increase absorption of calcium and phosphate from intestine.  Increase reabsorption of calcium and phosphate from bone.  Increase tubular reabsorption of calcium and phosphate in kidneys.  Cell differentiation: particularly of collagen and skin epithelium.  Important for cell mediated immunity and coordination of the immune response. 12
  • 13.  Calcitonin is secreted by the parafollicular cells, often called as C cells, situated amongst the follicles in the butterfly-shaped thyroid gland. Its normal plasma level is 1 to 2 ng/dL.  Calcitonin is a hypocalcemic hormone whose actions generally oppose those of PTH. • In Kidneys - Calcitonin inhibits reabsorption of calcium and phosphate from renal tubule and excreting them. • On Bones - Calcitonin inhibits osteoclasts and stimulates osteoblastic activity. Thus, decreasing plasma calcium as a result. CALCITONIN 13
  • 14. EFFECT ON BONE • Calcitonin binds to calcitonin receptor on basal osteoclast surface – G protein coupled receptor activation – Adenylate cyclase activation – ATP converted to 3’,5’-cAMP – Increase cAMP levels – decrease no. of osteocyte arms formed – decrease bone resorption. 14
  • 15. Physiological Functions of Calcium Controls of Excitability of Nerves and Muscle Maintains integrity of cell membrane and regulates cell adhesion Essential for muscular contraction Blood clotting Formation of bone and teeth Hormonal and neurotransmitter release Second messenger in some hormonal action 15
  • 16. REFERENCES • Osmosis from Elsevier, Calcium and phosphate regulation, n.d. https://www.osmosis.org/notes/Calcium_and_Phosphate_Hormonal_Regulation, accessed 15/04/2023. • Thomas D. Nolin and Peter A. Friedman, Agents affecting mineral ion homeostasis and bone turnover, The pharmacological basis of therapeutics, Goodman & Gilman’s, 13th edn. MC Graw Hill Education: 2018: 887-906. 16